Company News Summary
Mesoblast Reports Net Loss of $50.24m for Half-Year to 31 December 2020
05 Apr 2021 | 19:42:00 | Associate analysts | Increase | Decrease | 
Original announcement: Half Year Report and Accounts (including Appendix 4D)
Mesoblast reported net loss of $50.24m for the half-year ended 31 December 2020. Revenue from ordinary activities were $3.54m. Basic and Diluted EPS were (8.6) cents compared to (5.82) cents last year. The net operating cash outflow was $60.13m compared to an outflow of $16.89m in the pcp. No dividend was declared.
Mesoblast Half Year Results to 31 December 2020
| 6 Months to 31 December 2020 ($US'000) | 6 Months to 31 December 2019 ($US'000) | |
| Revenue | 3,546 | 19,254 |
| Pre-Tax Profit (Loss) | (50,892) | (34,269) |
| Net Profit (Loss) | (50,236) | (30,067) |
| Operating Cash Flow | (60,129) | (16,888) |
| Interim Dividends (cents) | nil | nil |
| Basic and Diluted EPS (cents) | (8.6) | (5.82) |
| NTA (cents) | (7.09) | (6.49) |
See more ASX300 News Announcements